Literature DB >> 20974464

Increased interstitial white matter neuron density in the dorsolateral prefrontal cortex of people with schizophrenia.

Yang Yang1, Samantha J Fung, Alice Rothwell, Si Tianmei, Cynthia Shannon Weickert.   

Abstract

BACKGROUND: Interstitial white matter neurons (IWMNs) may reflect immature neurons that migrate tangentially to the neocortex from the ganglionic eminence to form cortical interneurons. Alterations of interneuron markers have been detected in gray matter of dorsolateral prefrontal cortex in schizophrenia, and IWMNs are also reported to be altered in schizophrenia. In this study, we considered whether a potential link exists between these two pathological findings.
METHODS: From a cohort of 29 schizophrenia subjects and 37 control subjects, IWMN densities were determined in the dorsolateral prefrontal cortex by counting neuronal nuclear antigen (NeuN) and somatostatin (SST)-positive cells. Double-label immunofluorescence was carried out to determine the overlap between SST+/NeuN+ and SST+/neuropeptide Y + neurons.
RESULTS: We found that density of NeuN + IWMNs in superficial white matter is significantly increased in schizophrenia subjects compared with control subjects. There was a significant negative correlation between SST mRNA expression in gray matter and NeuN + IWMN density. In schizophrenic patients with increased NeuN IWMN density, the density of SST-expressing neurons in white matter was also higher compared with control subjects. A subpopulation of SST immunopositive cells also show coexpression of neuropeptide Y.
CONCLUSIONS: Our study confirmed previous results indicating that the density of NeuN + IWMNs is increased in superficial white matter in schizophrenia. We provide the first evidence that increased IWMN density correlates with a gray matter interneuron deficit, suggesting that migration of interneurons from white matter to the cortex may be deficient in some patients with schizophrenia, consistent with an interneuron deficit in schizophrenia.
Copyright © 2011 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20974464      PMCID: PMC3005941          DOI: 10.1016/j.biopsych.2010.08.020

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  54 in total

1.  Diminished dosage of 22q11 genes disrupts neurogenesis and cortical development in a mouse model of 22q11 deletion/DiGeorge syndrome.

Authors:  Daniel W Meechan; Eric S Tucker; Thomas M Maynard; Anthony-Samuel LaMantia
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-10       Impact factor: 11.205

2.  Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia.

Authors:  T Hashimoto; D Arion; T Unger; J G Maldonado-Avilés; H M Morris; D W Volk; K Mirnics; D A Lewis
Journal:  Mol Psychiatry       Date:  2007-05-01       Impact factor: 15.992

3.  Interaction between Reelin and Notch signaling regulates neuronal migration in the cerebral cortex.

Authors:  Kazue Hashimoto-Torii; Masaaki Torii; Matthew R Sarkisian; Christopher M Bartley; Jie Shen; Freddy Radtke; Thomas Gridley; Nenad Sestan; Pasko Rakic
Journal:  Neuron       Date:  2008-10-23       Impact factor: 17.173

4.  Alterations in somatostatin mRNA expression in the dorsolateral prefrontal cortex of subjects with schizophrenia or schizoaffective disorder.

Authors:  Harvey M Morris; Takanori Hashimoto; David A Lewis
Journal:  Cereb Cortex       Date:  2008-01-17       Impact factor: 5.357

5.  Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia.

Authors:  Takanori Hashimoto; H Holly Bazmi; Karoly Mirnics; Qiang Wu; Allan R Sampson; David A Lewis
Journal:  Am J Psychiatry       Date:  2008-02-15       Impact factor: 18.112

Review 6.  The neurotrophic and neuroprotective effects of psychotropic agents.

Authors:  Joshua Hunsberger; Daniel R Austin; Ioline D Henter; Guang Chen
Journal:  Dialogues Clin Neurosci       Date:  2009       Impact factor: 5.986

Review 7.  Neuroplasticity of neocortical circuits in schizophrenia.

Authors:  David A Lewis; Guillermo González-Burgos
Journal:  Neuropsychopharmacology       Date:  2007-09-05       Impact factor: 7.853

8.  Decreased glutamic acid decarboxylase(67) mRNA expression in multiple brain areas of patients with schizophrenia and mood disorders.

Authors:  Mia Thompson; Cynthia Shannon Weickert; Eugene Wyatt; Maree J Webster
Journal:  J Psychiatr Res       Date:  2009-03-24       Impact factor: 4.791

9.  Doublecortin expression in adult cat and primate cerebral cortex relates to immature neurons that develop into GABAergic subgroups.

Authors:  Yan Cai; Kun Xiong; Yaping Chu; Duan-Wu Luo; Xue-Gang Luo; Xian-Yui Yuan; Robert G Struble; Richard W Clough; Dennis D Spencer; Anne Williamson; Jeffrey H Kordower; Peter R Patrylo; Xiao-Xin Yan
Journal:  Exp Neurol       Date:  2008-12-25       Impact factor: 5.330

10.  Cingulate white matter neurons in schizophrenia and bipolar disorder.

Authors:  Caroline M Connor; Yin Guo; Schahram Akbarian
Journal:  Biol Psychiatry       Date:  2009-06-25       Impact factor: 13.382

View more
  49 in total

Review 1.  MicroRNA dysregulation in neuropsychiatric disorders and cognitive dysfunction.

Authors:  Bin Xu; Pei-Ken Hsu; Maria Karayiorgou; Joseph A Gogos
Journal:  Neurobiol Dis       Date:  2012-03-03       Impact factor: 5.996

Review 2.  Transcriptional co-regulation of neuronal migration and laminar identity in the neocortex.

Authors:  Kenneth Y Kwan; Nenad Sestan; E S Anton
Journal:  Development       Date:  2012-05       Impact factor: 6.868

3.  Investigation of anatomical thalamo-cortical connectivity and FMRI activation in schizophrenia.

Authors:  Stefano Marenco; Jason L Stein; Antonina A Savostyanova; Fabio Sambataro; Hao-Yang Tan; Aaron L Goldman; Beth A Verchinski; Alan S Barnett; Dwight Dickinson; José A Apud; Joseph H Callicott; Andreas Meyer-Lindenberg; Daniel R Weinberger
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

4.  Increased density of DISC1-immunoreactive oligodendroglial cells in fronto-parietal white matter of patients with paranoid schizophrenia.

Authors:  Hans-Gert Bernstein; Esther Jauch; Henrik Dobrowolny; Christian Mawrin; Johann Steiner; Bernhard Bogerts
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-08-28       Impact factor: 5.270

Review 5.  Post-transcriptional regulatory elements and spatiotemporal specification of neocortical stem cells and projection neurons.

Authors:  E M DeBoer; M L Kraushar; R P Hart; M-R Rasin
Journal:  Neuroscience       Date:  2013-05-30       Impact factor: 3.590

Review 6.  Transcriptional regulation of GAD1 GABA synthesis gene in the prefrontal cortex of subjects with schizophrenia.

Authors:  Amanda C Mitchell; Yan Jiang; Cyril Peter; Schahram Akbarian
Journal:  Schizophr Res       Date:  2014-10-31       Impact factor: 4.939

Review 7.  Neurodevelopment, GABA system dysfunction, and schizophrenia.

Authors:  Martin J Schmidt; Karoly Mirnics
Journal:  Neuropsychopharmacology       Date:  2014-04-24       Impact factor: 7.853

8.  Alterations of superficial white matter in schizophrenia and relationship to cognitive performance.

Authors:  Arash Nazeri; M Mallar Chakravarty; Daniel Felsky; Nancy J Lobaugh; Tarek K Rajji; Benoit H Mulsant; Aristotle N Voineskos
Journal:  Neuropsychopharmacology       Date:  2013-04-16       Impact factor: 7.853

Review 9.  Early developmental disturbances of cortical inhibitory neurons: contribution to cognitive deficits in schizophrenia.

Authors:  David W Volk; David A Lewis
Journal:  Schizophr Bull       Date:  2014-07-22       Impact factor: 9.306

10.  NeuN+ neuronal nuclei in non-human primate prefrontal cortex and subcortical white matter after clozapine exposure.

Authors:  Tobias B Halene; Alexey Kozlenkov; Yan Jiang; Amanda C Mitchell; Behnam Javidfar; Aslihan Dincer; Royce Park; Jennifer Wiseman; Paula L Croxson; Eustathia Lela Giannaris; Patrick R Hof; Panos Roussos; Stella Dracheva; Scott E Hemby; Schahram Akbarian
Journal:  Schizophr Res       Date:  2016-01-06       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.